Latest ArticlesTo systematically evaluate the pharmacological effects and molecular mechanisms of Danlou tablets with comprehensive pharmacological strategies, and to provide a theoretical basis for the treatment of diabetic cardiomyopathy (DCM).
The chemical constituents and targets of Danlou tablets were discovered from the platform of pharmacology analysis of traditional Chinese medicine system, and the interaction network of "component-target" was established. All the targets of DCM were screened through the database, the relationship diagram of "component-disease target" was constructed. The core targets were screened, and the gene ontology analysis and the related pathway enrichment were performed on the core targets. The DCM rat model was treated with Danlou tablets to verify the predicted important signaling pathways.
A total of 190 compound nodes and 275 target nodes were screened from 10 important formulations of Danlou tablet. A total of 19 targets related to DCM were screened from Danlou tablet, and 103 target related pathways had role in DCM. In vivo, Danlou tablet reduced the expression of fibrosis-related factor messenger RNA in myocardium of DCM rats and inhibited the expression of receptor for advanced glycation end products (RAGE)/nuclear factor (NF)-κB/nucleotide-binding oligomerization domain-like receptor protein (NLRP)3 pathway-related proteins RAGE and NLRP3, and phosphorylation of NF-κB (p65) protein.
Danlou tablets can inhibit myocardial fibrosis in DCM rats by blocking the activation of RAGE/NF-κB/NLRP3 signaling pathway, and then inhibiting the progression of the disease.
To explore the effect of Xuanfei Tongluo Pingchuan decoction combined with probiotics in the treatment of bronchial asthma.
A total of 100 patients with bronchial asthma who were hospitalized in department of geriatric, Tangshan Fengnan District Hospital from October 2018 to October 2021 were selected and randomly divided into control group (probiotics) and experimental group (probiotics+Xuanfei Tongluo Pingchuan decoction), and 50 cases in each group. The clinical efficacy, recurrence, serum levels of gastrointestinal hormones, inflammatory factors, lung function and adverse reactions of the two groups were compared.
The curative effect of the experimental group was obviously better than that of the control group (P<0.05). The 6-month recurrence rate of asthma and the number of patients with more than 2 acute attacks in the experimental group were significantly lower than those in the control group (P<0.05). After treatment, the levels of gastrin (GAS) in the two groups increased, and the levels of eosinophil (EOS), immunoglobulin E (IgE), C-reactive protein (CRP), tumor necrosis factor-α(TNF-α) and interleukin-6 (IL-6) decreased, and the levels of GAS in the experimental group was obviously higher than that in the control group, and the levels of EOS, IgE, CRP, TNF-α, and IL-6 were obviously lower than those in the control group (P<0.05). After treatment, forced expiratory volume in first second (FEV1), peak expiratory flow rate and FEV1/forced vital capacity ratio in the two groups increased, and the experimental group were obviously higher than those in the control group (P<0.05).
Xuanfei Tongluo Pingchuan decoction combined with probiotics can significantly improve the clinical efficacy of bronchial asthma patients, reduce asthma recurrence, improve gastrointestinal hormone levels and inflammatory reactions, enhance lung function, and have good safety.
To compare and analyze the effect of ursodeoxycholic acid combined with biliary stent drainage and biliary stent drainage alone in the treatment of biliary stricture.
Patients with biliary stricture who treated by endoscopic retrograde cholangiopancreatography (ERCP) in our hospital were collected from June 2019 to June 2021. The patients were divided into experimental group (ursodeoxycholic acid combined with biliary stent, 158 cases) and control group (biliary stent, 162 cases). The levels of total bilirubin (TBil) and alanine transaminase (ALT) before and after ERCP were analyzed. The complications were analyzed and the recurrence of biliary stricture was followed up for 6 months after ERCP.
After treatment, the levels of TBil and ALT in the two groups were significantly lower than those before treatment (P<0.05). There was no significant difference in the incidence of complications between the two groups (P>0.05). After 6 months of follow-up, the recurrence rate of biliary stricture in the control group was higher, and the difference was statistically significant (P<0.05).
Both two groups can reduce jaundice, and ursodeoxycholic acid combined with biliary stent has a lower recurrence rate in the treatment of biliary stricture.
To evaluate the bioequivalence, skin adhesion, irritation and safety of test preparation and reference preparation of 5% lidocaine gel patch on the skin of healthy volunteers under topical application condition.
A single-center, randomized, open-label, single-dose, two-cycle, two-sequence, two-crossover trial was designed. Thirty healthy subjects were randomly divided into RT group and TR group, subjects in RT group were treated with the reference preparation in the first cycle, and test preparation in the second cycle. Subjects in the TR group were treated with the test preparation in the first cycle, and reference preparation in the second cycle. The cleaning period was 3 days, 3 patches each time and continuous application for 12 h. The internal standard method and statistical method were used to calculate the main pharmacokinetic parameters, and the bioequivalence, adhesion and skin irritation of the two formulations were analyzed.
The 90% confidence interval for the geometric mean ratio of plasma peak concentration of the test preparation and the reference preparation, the area under the blood concentration-time curve from 0 to the time t that can be accurately measured, and the area under the blood concentration-time curve from 0 to infinite time were all 80.00% to 125.00%. The adhesive force of the two formulations were completely consistent among all subjects at all time points. There was no statistically significant difference in skin irritation between the test preparation and the reference preparation (P>0.05).
The test preparation was bioequivalent to the reference preparation, with good safety, and the test preparation was not inferior to the reference preparation in adhesive force, and there was no difference in skin irritation.
To analyze and compare the clinical efficacy of dexmedetomidine and remifentanil combined with propofol in painless induced abortion, and the effects of T cytokines, vital signs, and sexual hallucinations.
A total of 100 early pregnancy pregnant women who underwent painless induced abortion in our hospital from December 2018 to December 2020 were selected and divided into control group (dexmedetomidine+propofol) and study group (remifentanil+propofol) according to random number method, with 50 cases in each group. Anesthesia induction time, anesthesia effect, recovery time and discharge time of the two groups were observed. Serum interleukin (IL)-1β, IL-10, mean arterial pressure (MAP), heart rate (HR), pulse oxygen saturation (SpO2) changes and the incidence of sexual hallucinations were also observed.
MAP and HR of the two groups after induction, during operation and after operation were lower than those before operation, and MAP and HR of the study group were higher than those of the control group at all periods (P<0.05). The difference of IL-1β and IL-10 levels in the study group before and after anesthesia was significantly lower than those in the control group (P<0.05). Compared with the control group, the incidence of sexual hallucinations in the study group was significantly lower after anesthesia (14% vs 36%). Anesthesia induction time [(122.08±21.49) s vs (82.92±11.41)s], recovery time [(3.58±1.05)min vs (3.08±1.03)min] and discharge time [(31.34±5.57)min vs (28.12±4.75)min] were significantly shortened. The total effective rate of anesthesia was significantly improved (80% vs 98%, P<0.05). Compared with the control group, serum IL-1β level was significantly decreased [(0.31±0.07)ng/ml vs (0.23±0.06)ng/ml] and serum IL-10 level was significantly increased [(36.41±12.34)pg/ml vs (44.96±11.02)pg/ml] after anesthesia.
The combination of remifentanil and propofol has better anesthetic effect than dexmedetomidine and propofol. The intraoperative vital signs are more stable, the inflammatory reaction is lighter, and the incidence of sexual hallucination is lower.
To compare the difference of microbiota between lesions and non-lesions of elbow fossa in children with infantile atopic dermatitis (AD) and childhood AD, and to analyze the effect of emollient therapy on skin microbiota in mild pediatric AD patients.
By using self-control study, Illumina MiSeq sequencing platform was used to sequence the V3—V4 region of 16S ribosome DNA gene on the skin surface of AD children with and without skin lesions, and on the same skin lesion before and after treatment with emollient. The differences of microbiota between skin lesions and non-skin lesions and before and after treatment with emollient were compared.
A total of 35 children with AD were included in the study. Compared with the normal skin without skin lesions, the abundance of staphylococci in AD elbow lesions was significantly increased and the α diversity of microbiota decreased significantly (P<0.05), and there was no significant difference between infantile AD and childhood AD. One month after treatment, Staphylococcus aureus changed from dominant microbiota to non-dominant microbiota.
Staphylococci colonization is the dominant bacteria in the skin lesions of infants with AD and childhood AD, and there is no difference in the composition of microbiota with age, and emollient treatment can change Staphylococcus aureus in skin lesions of mild childhood AD patients from dominant microbiota to non-dominant microbiota.
To systematically evaluate the efficacy and safety of enteral nutrition preparations containing ω-3 polyunsaturated fatty acids or standard enteral nutrition preparations in patients with upper gastrointestinal cancer during the perioperative period, and to provide reference for clinical rational drug use.
Pubmed, EMbase, the Cochrane Library, CNKI, and Wanfang databases were searched for relevant literature. The search time limit was from the establishment of the database to June 1, 2022. Two researchers independently screened the literature, extracted data and assessed the risk of bias of the included studies. Stata16.0 software was used for meta-analysis.
A total of 38 randomized controlled trials were included. The results of meta-analysis showed that compared with the standard enteral nutrition, enteral nutrition preparations containing ω-3 polyunsaturated fatty acids were more effective in reducing the infectious complications (relative risk=0.75, P<0.001), improving immune and inflammation-related indicators, albumin, and reducing the length of hospital stay (weighted mean differenc=-2.321, P<0.05).
Enteral nutrition preparations containing ω-3 polyunsaturated fatty acids have advantages in efficacy and safety in postoperative nutritional therapy for upper gastrointestinal cancer, and can be used as the preferred clinical drug. Limited by the quantity and quality of the included studies, the above conclusions need to be verified by more high-quality studies.